Home

One in two people will have cancer by age 85 and yet research shows compared to younger patients they have less access to acute treatments, information on side-effects and opportunities to take part in clinical trials.

Peter Mac researchers feature in this week’s American Association of Cancer Research program, which is expected to attract up to 30,000 clinicians and researchers worldwide.

For patients with some hard-to-treat blood cancers, a new “off-the-shelf” immunotherapy is achieving promising results.